NG01 cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NG01 cell therapy, covering 2025-05-07 to 2025-05-07. Get the full timeline:
Most recent: Clinical Trial Update: Study of NG01 Cell Therapy in Secondary Progressive Multiple Sclerosis [Phase 2]